Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Wiemann

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Comprehensive Therapy|March 1, 1983
Principles of current cancer chemotherapyM C Wiemann, P Calabresi
Indiana Medicine : the Journal of the Indiana State Medical Association|August 1, 1991
Clinical use of interleukin-2 in treating cancerD L Patterson, M C Wiemann
Journal of the National Cancer Institute|July 1, 1987
Artificial capillary culture studies of human tumor cell growth, differentiation, and marker productionM C Wiemann, D L Dexter, P Calabresi
Minerva Ginecologica|February 25, 2005
Chemotherapy for ovarian cancer: an evidence-based approachJ P Geisler, K J Manahan, M C Wiemann
Chest|July 1, 1993
Carmustine toxicity presenting as a lobar infiltrateD L Patterson, M C Wiemann, T H Lee, et al.
Gynecologic Oncology|March 1, 1996
Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovaryJ P Geisler, M C Wiemann, G A Miller, et al.
Biochemical and Biophysical Research Communications|January 16, 1985
Detection of a novel cyclooxygenase metabolite produced by human promyelocytic leukemia (HL-60) cellsA P Agins, A B Hollmann, K C Agarwal, et al.
Gynecologic Oncology|September 10, 1999
What staging surgery should be performed on patients with uterine papillary serous carcinoma?J P Geisler, H E Geisler, M E Melton, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 1, 1997
Hybrid high-dose bolus/continuous infusion interleukin-2 in patients with metastatic renal cell carcinoma: a phase II trial of the National Biotherapy Study GroupR O Dillman, M C Wiemann, M J Bury, et al.
Gynecologic Oncology|June 1, 1996
Proliferation index determined by MIB-1 and recurrence in endometrial cancerJ P Geisler, M C Wiemann, Z Zhou, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Comprehensive Therapy|March 1, 1983
Principles of current cancer chemotherapyM C Wiemann, P Calabresi
Indiana Medicine : the Journal of the Indiana State Medical Association|August 1, 1991
Clinical use of interleukin-2 in treating cancerD L Patterson, M C Wiemann
Journal of the National Cancer Institute|July 1, 1987
Artificial capillary culture studies of human tumor cell growth, differentiation, and marker productionM C Wiemann, D L Dexter, P Calabresi
Minerva Ginecologica|February 25, 2005
Chemotherapy for ovarian cancer: an evidence-based approachJ P Geisler, K J Manahan, M C Wiemann
Chest|July 1, 1993
Carmustine toxicity presenting as a lobar infiltrateD L Patterson, M C Wiemann, T H Lee, et al.
Gynecologic Oncology|March 1, 1996
Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovaryJ P Geisler, M C Wiemann, G A Miller, et al.
Biochemical and Biophysical Research Communications|January 16, 1985
Detection of a novel cyclooxygenase metabolite produced by human promyelocytic leukemia (HL-60) cellsA P Agins, A B Hollmann, K C Agarwal, et al.
Gynecologic Oncology|September 10, 1999
What staging surgery should be performed on patients with uterine papillary serous carcinoma?J P Geisler, H E Geisler, M E Melton, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 1, 1997
Hybrid high-dose bolus/continuous infusion interleukin-2 in patients with metastatic renal cell carcinoma: a phase II trial of the National Biotherapy Study GroupR O Dillman, M C Wiemann, M J Bury, et al.
Gynecologic Oncology|June 1, 1996
Proliferation index determined by MIB-1 and recurrence in endometrial cancerJ P Geisler, M C Wiemann, Z Zhou, et al.
Pageof 6